The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of DPLO, HCSG and INGN

In This Article:

NEW YORK, NY / ACCESSWIRE / April 14, 2019 / The Klein Law Firm announces that class action complaints have been filed on behalf of shareholders of the following companies. If you suffered a loss you have until the lead plaintiff deadline to request that the court appoint you as lead plaintiff.

Diplomat Pharmacy, Inc. (DPLO)
Class Period: February 26, 2018 to February 21, 2019
Lead Plaintiff Deadline: April 25, 2019

The complaint alleges that during the class period Diplomat Pharmacy, Inc. made materially false and/or misleading statements and/or failed to disclose that: (1) Diplomat had downplayed its success in integrating and growing its PBM business, which included LDI Integrated and National Pharmaceutical, two companies Diplomat had acquired in late 2017; (2) consequently, Diplomat would need to record a non-cash impairment charge upwards of approximately $630 million relating to its PBM business and these 2017 acquisitions; (3) due to the foregoing, Diplomat would withdraw its preliminary 2019 full-year outlook issued less than seven weeks prior; and (4) as a result, defendants' statements about Diplomat's business, operations and prospects were materially false and misleading and/or lacked a reasonable basis at all relevant times.

Get additional information about the DPLO lawsuit: http://www.kleinstocklaw.com/pslra-1/diplomat-pharmacy-inc-loss-submission-form?id=1092&from=1

Healthcare Services Group, Inc. (HCSG)
Class Period: April 11, 2017 to March 4, 2019
Lead Plaintiff Deadline: May 21, 2019

According to the complaint, Healthcare Services Group, Inc. allegedly made materially false and/or misleading statements and/or failed to disclose that: (a) Defendant Wahl either knew or was reckless in not knowing that the Company had been accused of strategically rounding quarterly earnings per share, and therefore investors could not rely upon the Company's track record without conducting a thorough investigation into the allegations; (b) Defendants concealed that the SEC had written to the Company in November 2017 to inquire into the Company's earnings per share rounding practices; and (c) the Company concealed that the SEC delivered a subpoena to the Company in March 2018 demanding the Company produce documents in connection with how it calculated earnings per share.

Get additional information about the HCSG lawsuit: http://www.kleinstocklaw.com/pslra-1/healthcare-services-group-inc-loss-submission-form?id=1092&from=1

Inogen, Inc. (INGN)
Class Period: November 8, 2017 to February 26, 2019
Lead Plaintiff Deadline: May 6, 2019